X

pharmaceuticals

AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope

With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs,…

UnitedHealth Group (UNH) is headed for a weak second half. Here’s why

For UnitedHealth Group Inc. (NYSE: UNH), the early effect of coronavirus on its business was a marked reduction in costs…

Bristol Myers looks to expand cardiovascular portfolio with MyoKardia acquisition

Bristol Myers Squibb (NYSE: BMY) agreed to acquire MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion in cash. The deal, which…

After initial hiccups, Cigna (CI) looks to emerge healthier post-COVID

The healthcare sector was required to respond to the coronavirus outbreak in a proactive manner, unlike most other businesses. Cigna…

AMAG Pharmaceuticals Inc (AMAG) Q2 2020 Earnings Call Transcript

AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Rushmie Nofsinger -- Executive Director of Corporate…

What makes CVS Health a better investment option than Walgreens

https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at…

Rite Aid Corp (RAD) Q2 2021 Earnings Call Transcript

Rite Aid Corp (NYSE: RAD) Q2 2021 earnings conference call dated September 24, 2020   Corporate Participants: Trent Kruse -- Senior Vice…

Rite Aid’s (RAD) loss narrows in Q2 2021

Rite Aid Corporation (NYSE: RAD) reported a narrower loss in the second quarter of 2021. Net loss shrank to $0.25…

Aurora Cannabis (ACB) banks on premium brands after disastrous Q4

Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report…

Aurora Cannabis Inc. (ACB) Q4 2020 Earnings Call Transcript

Aurora Cannabis Inc  (NYSE: ACB) Q4 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer and…

Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease…

ERYTECH Pharma S.A. (ERYP) Q2 2020 Earnings Call Transcript

ERYTECH Pharma S.A. (NASDAQ: ERYP) Q2 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Gil Beyen -- Chief Executive Officer Eric…

Moderna (MRNA) set to take advantage of opportunity in vaccines

Shares of Moderna Inc. (NASDAQ: MRNA) have gained 246% since the beginning of this year and more than 279% over…

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare…

Humana (HUM) can offer long-term returns despite high valuation

https://www.youtube.com/watch?v=zOVB6xD8rS4 There has been a marked decrese in the number of people seeking healthcare services since the virus outbreak but…

COVID-19 vaccine development: A look at some of the pharma companies and their progress

The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict…

Medtronic (MDT) revisits business strategy even as recovery gathers steam

https://www.youtube.com/watch?v=ukh0vaOtvBw For Medtronic plc (NYSE:MDT), the last two quarters were disappointing as healthcare institutions postponed routine medial procedures and channeled…

Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?

Being part of a rapidly growing industry and having a successful business model can be a winning combination in difficult…

Stable demand should help PetMed (PETS) emerge stronger from pandemic

PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market…

CureVac (CVAC): Another COVID-19 stock that attracted investors

In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19…

Veru Inc. (VERU) Q3 2020 Earnings Call Transcript

Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman,…